HPVomics

A therapeutic and epitome resource for Human Papillomaviruses

Efficient putative LR-HPVs E7 protein epitopes (MHC-I Binders)



S.No. HPV type Target region Peptide seuences Start End Length Allele Percentile rank ann_ic50 smm_ic50
1 HPV6 E7 GTLNIVCPI 85 93 9 HLA-A*32:01 0.3 9.59 26.24
2 HPV6 E7 IVCPICAPK 89 97 9 HLA-A*11:01 0.35 21.42 33.37
3 HPV6 E7 NIVCPICAPK 88 97 10 HLA-A*68:01 0.4 30.47 15.38
4 HPV6 E7 LLLGTLNIV 82 90 9 HLA-A*02:01 0.6 25.78 30.77
5 HPV6 E7 LLLGTLNIV 82 90 9 HLA-A*02:03 0.7 11.96 24.54
6 HPV6 E7 LLLGTLNIV 82 90 9 HLA-A*02:06 0.75 14.78 31.44
7 HPV6 E7 GLHCYEQLV 22 30 9 HLA-A*02:03 0.85 24.83 29.71
8 HPV11 E7 GTLNIVCPI 85 93 9 HLA-A*32:01 0.3 9.59 26.24
9 HPV11 E7 IVCPICAPK 89 97 9 HLA-A*11:01 0.35 21.42 33.37
10 HPV11 E7 NIVCPICAPK 88 97 10 HLA-A*68:01 0.4 30.47 15.38
11 HPV11 E7 LLLGTLNIV 82 90 9 HLA-A*02:01 0.6 25.78 30.77
12 HPV11 E7 LLLGTLNIV 82 90 9 HLA-A*02:03 0.7 11.96 24.54
13 HPV11 E7 LLLGTLNIV 82 90 9 HLA-A*02:06 0.75 14.78 31.44
14 HPV40 E7 LLMGTLHIV 95 103 9 HLA-A*02:01 0.2 5.5 6.1
15 HPV40 E7 LLMGTLHIV 95 103 9 HLA-A*02:03 0.2 2.69 2.53
16 HPV40 E7 RPTLGDIVL 5 13 9 HLA-B*07:02 0.2 21.2 24.6
17 HPV40 E7 LLMGTLHIV 95 103 9 HLA-A*02:06 0.25 9.11 9.5
18 HPV40 E7 QLLMGTLHIV 94 103 10 HLA-A*02:01 0.4 24.18 34.31
19 HPV40 E7 VLNLHPEPV 12 20 9 HLA-A*02:03 0.4 7.56 9.86
20 HPV40 E7 CVFCQCLVR 71 79 9 HLA-A*68:01 0.45 35.3 22.83
21 HPV40 E7 QLLMGTLHIV 94 103 10 HLA-A*02:03 0.5 10.81 26.32
22 HPV42 E7 MLLGTLDIV 77 85 9 HLA-A*02:06 0.4 6.8 18.77
23 HPV42 E7 MLLGTLDIV 77 85 9 HLA-A*02:01 0.4 14.38 18.88
24 HPV42 E7 MLLGTLDIV 77 85 9 HLA-A*02:03 0.75 11.6 25.52
25 HPV43 E7 CTSCLCVIR 58 66 9 HLA-A*68:01 0.3 14.01 23.91
26 HPV44 E7 LQLEPPDPV 13 21 9 HLA-A*02:06 0.25 6.29 8.62
27 HPV44 E7 GSLDILCPV 84 92 9 HLA-A*02:06 0.35 4.48 16.16
28 HPV54 E7 NVATIEDIV 4 12 9 HLA-A*68:02 0.4 14.01 22.37
29 HPV54 E7 LLHQDALQIV 78 87 10 HLA-A*02:03 0.5 11.88 22.5
30 HPV54 E7 ETAVTQPDK 36 44 9 HLA-A*68:01 0.6 23.16 32.32
31 HPV61 E7 LLLGDLSIV 82 90 9 HLA-A*02:03 0.35 6.65 12.36
32 HPV61 E7 LLLGDLSIV 82 90 9 HLA-A*02:01 0.5 15.91 21.93
33 HPV61 E7 TIKDIVLEER 7 16 10 HLA-A*68:01 0.5 28.44 29.17
34 HPV61 E7 QVATIKDIV 4 12 9 HLA-A*68:02 0.5 13.7 34.09
35 HPV61 E7 LLLGDLSIV 82 90 9 HLA-A*02:06 0.55 11.13 28.09
36 HPV61 E7 IVLEERPEV 11 19 9 HLA-A*02:06 0.7 18.69 22.68
37 HPV61 E7 LVEQAQQAY 44 52 9 HLA-B*35:01 0.7 14.41 38.42
38 HPV70 E7 LQLFMETLSF 90 99 10 HLA-B*15:01 0.1 3.8 0.22
39 HPV70 E7 METLSFVCPW 94 103 10 HLA-B*44:03 0.15 14.26 23.39
40 HPV70 E7 QLFMETLSFV 91 100 10 HLA-A*02:03 0.15 3.55 4.3
41 HPV70 E7 QLFMETLSFV 91 100 10 HLA-A*02:01 0.2 11.1 8.9
42 HPV70 E7 RPTLQEIVL 5 13 9 HLA-B*07:02 0.3 30.77 38.18
43 HPV70 E7 LFMETLSFV 92 100 9 HLA-A*02:06 0.55 22.75 12.18
44 HPV72 E7 DNLSIVCPR 90 98 9 HLA-A*33:01 0.25 19.06 22.7
45 HPV72 E7 LLLDNLSIV 87 95 9 HLA-A*02:03 0.25 3.5 7.06
46 HPV72 E7 VTTCGRCYR 60 68 9 HLA-A*31:01 0.25 9.8 18.68
47 HPV72 E7 LLLDNLSIV 87 95 9 HLA-A*02:01 0.3 6.75 13.25
48 HPV72 E7 LLLDNLSIV 87 95 9 HLA-A*02:06 0.35 7.31 17.97
49 HPV72 E7 VTTCGRCYR 60 68 9 HLA-A*68:01 0.4 17.62 27.57
50 HPV72 E7 VVTTCGRCYR 59 68 10 HLA-A*31:01 0.4 37.58 34.95
51 HPV72 E7 QVATIKDIV 4 12 9 HLA-A*68:02 0.5 13.7 34.09
52 HPV72 E7 LVEQAQQAY 49 57 9 HLA-B*35:01 0.7 14.41 38.42
53 HPV72 E7 QLLLDNLSIV 86 95 10 HLA-A*02:03 0.75 20.58 32.38
54 HPV81 E7 LLTDTLSIV 85 93 9 HLA-A*02:03 0.25 2.96 7.29
55 HPV81 E7 QLLTDTLSIV 84 93 10 HLA-A*02:03 0.5 15.35 15.01
56 HPV81 E7 TTCGICRCLV 59 68 10 HLA-A*68:02 0.55 26.99 31.21
57 HPV81 E7 LVEQAQQAY 47 55 9 HLA-B*35:01 0.7 14.41 38.42